Currently, there are 989.09M common shares owned by the public and among those 988.41M shares have been available to trade.
The company’s stock has a 5-day price change of 4.93% and 27.55% over the past three months. BKR shares are trading 14.68% year to date (YTD), with the 12-month market performance up to 52.38% higher. It has a 12-month low price of $28.32 and touched a high of $47.47 over the same period. BKR has an average intraday trading volume of 6.49 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.73%, 9.71%, and 28.38% respectively.
Institutional ownership of Baker Hughes Co (NASDAQ: BKR) shares accounts for 94.74% of the company’s 989.09M shares outstanding.
It has a market capitalization of $46.55B and a beta (3y monthly) value of 1.37. The stock’s trailing 12-month PE ratio is 21.07, while the earnings-per-share (ttm) stands at $2.23. The company has a PEG of 0.66 and a Quick Ratio of 0.88 with the debt-to-equity ratio at 0.37. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.28% over the week and 2.45% over the month.
Analysts forecast that Baker Hughes Co (BKR) will achieve an EPS of 0.63 for the current quarter, 0.52 for the next quarter and 2.55 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.6 while analysts give the company a high EPS estimate of 0.6. Comparatively, EPS for the current quarter was 0.51 a year ago. Earnings per share for the fiscal year are expected to increase by 44.35%, and 10.39% over the next financial year. EPS should shrink at an annualized rate of 31.83% over the next five years, compared to 33.59% over the past 5-year period.
Looking at the support for the BKR, a number of firms have released research notes about the stock. Piper Sandler stated their Overweight rating for the stock in a research note on December 19, 2024, with the firm’s price target at $53. Wells Fargo was of a view on September 25, 2024 that the stock is Overweight, while TD Cowen gave the stock Buy rating on July 29, 2024, issuing a price target of $46- $50. Wolfe Research on their part issued Peer Perform rating on January 29, 2024.
